No. lesions/total No. (%) |
110/131 (84) |
21/131 (16) |
– |
Median age (range) |
60.0 (45.0–78.0) |
62.0 (47.0–74.0) |
0.451 |
Median ng/ml prebiopsy PSA (range) |
5.12 (1.23–24.80) |
4.97 (1.67–13.22) |
0.205 |
Median cm initial lesion diameter (range) |
0.80 (0.30–3.0) |
0.90 (0.30–2.1) |
0.232 |
No. max initial GS/total No. (%): |
|
|
0.121 |
Benign |
55/110 (50) |
7/21 (33.3) |
|
3 + 3 |
42/110 (38.2) |
13/21 (61.9) |
|
3 + 4 |
13/110 (11.8) |
1/21 (4.8) |
|
No. anterior lesions/total No. (%) |
31/131 (28.2) |
4/21 (19.0) |
0.282 |
No. initial MRI suspicion score/total No. (%): |
|
|
0.821 |
Low |
35/110 (31.8) |
7/21 (33.3) |
|
Moderate |
73/110 (66.4) |
14/21 (66.7) |
|
High |
2/110 (1.8) |
0/21 (0) |
|
Median ng/ml repeat biopsy PSA (range) |
5.31 (0.83–36.62) |
4.82 (1.28–21.35) |
0.422 |
Median days to repeat (range): |
|
|
|
mpMRI |
497.5 (240–1,694) |
475.0 (364–2,742) |
0.537 |
Biopsy |
530.0 (108–2,581) |
517.0 (364–2,418) |
0.900 |
Median cm final lesion size (range) |
0.750 (0.30–3.10) |
1.10 (0.30–2.30) |
0.060 |
Mean ± SD lesion size increase (mm) |
−0.316 ± 1.993 |
0.710 ± 2.444 |
0.104 |
Mean ± SD growth rate (mm/yr) |
−0.203 ± 1.082 |
0.143 ± 1.573 |
0.143 |
Mean ± SD PSA increase (ng/ml) |
0.25 ± 3.53 |
0.45 ± 2.58 |
0.115 |